#United States #Corona #BIOLASE #MegaGen #Waterlase

MegaGen and BIOLASE Boost Manufacturing with Significant Investment

In a transformative move for the dental technology industry, BIOLASE, a leading player in dental laser innovations and part of the MegaGen family, has made a substantial investment of nearly $1 million to upgrade their manufacturing facility located in Corona, California. This project not only aims to expand production capacity but also focuses on enhancing overall quality and supply chain stability, particularly for their flagship products, the Waterlase and Epic dental laser systems.

The investment will be used for various enhancements, including the construction of new cleanrooms, laser room upgrades, and improving facilities that support the assembly and handling of laser fibers. Such precision in manufacturing is essential to meet the growing demands of clinicians worldwide, ensuring that advanced laser technologies are produced under the strictest quality conditions.

Key Aspects of the Investment

This initiative will involve significant structural developments at the Corona facility:

• - Expanded Cleanroom Facilities: New cleanrooms will be designed to precisely construct and assemble laser technologies, maintaining the highest quality assurance.
• - Enhanced Employee Areas: Facilities such as changing rooms, cafeterias, and lunch areas will be built to support the workforce, promoting a productive working environment that aligns with the rigorous standards of manufacturing BIOLASE is known for.
• - Improved Manufacturing Infrastructure: Upgrades will include enhanced capabilities for material handling and product flow, ensuring that the new systems can operate efficiently and meet the industry’s stringent demands.

A Broader Strategic Vision

This investment signifies a deeper commitment from both BIOLASE and MegaGen to support their global growth objectives. The Corona facility is poised to become a crucial hub for scientific innovation and advanced manufacturing. As MegaGen takes charge of BIOLASE's international sales operations, they seek to bolster the distribution networks of laser technologies, facilitating greater access for clinicians across various markets.

Jung Hwan Lim, COO and Senior Vice President of BIOLASE, emphasized the importance of this investment, stating, "Southern California has been an important technology center for BIOLASE for decades. This project strengthens our ability to support clinicians with the quality, reliability, and continuity they expect from Waterlase and Epic laser technologies."

Supporting Clinicians

BIOLASE's Waterlase and Epic systems have revolutionized dental procedures, offering minimally invasive treatments that enhance patient care models. Enhancing the manufacturing backbone allows these innovations to seamlessly integrate into everyday dental practices, proving beneficial to dentists, specialists, and distributors alike.

Future plans include expansions in clinical education and training programs to ensure that dentists can adopt these advanced laser technologies with confidence. The adjustments in manufacturing are geared towards not just increasing production, but also fostering a culture of innovation that aligns with the demands of modern dental care.

Conclusion

As MegaGen and BIOLASE embark on this ambitious project, they aim to set new standards within the dental technology landscape, enhancing quality, reliability, and overall service continuity for healthcare professionals. This investment reflects their ongoing dedication to clinical excellence and innovative solutions that enhance patient care, securing their position as a leader in dental laser technology.